Authors:
VANDEFLIERDT E
FRANK T
LAUBENBACHER C
FINK U
BAUER R
LANGHAMMER HR
PABST HW
Citation: E. Vandeflierdt et al., CLINICAL RELEVANCE OF I-123 I-131-MIBG-SC INTIGRAPHY IN INTESTINAL CARCINOIDS/, Nuklearmedizin, 37(4), 1998, pp. 129-133
Authors:
HIRSCH C
SPYRA JL
LANGHAMMER HR
LAUBENBACHER C
SENEKOWITSCHSCHMIDTKE R
SCHWAIGER M
Citation: C. Hirsch et al., PREVALENCE OF GRAVES-DISEASE FOLLOWING TR EATMENT OF AUTONOMOUS GOITER WITH I-131 THERAPY, Medizinische Klinik, 92(3), 1997, pp. 130-137
Authors:
TATSCH K
WEBER W
ROSSMULLER B
LANGHAMMER HR
SCHWAIGER M
HAHN K
Citation: K. Tatsch et al., FDG-PET IN PATIENTS WITH THYROID-CARCINOMA PRESENTING WITH ELEVATED THYROGLOBULIN BUT NEGATIVE IODINE-SCAN AND SESTAMIBI-SCAN, The Journal of nuclear medicine, 38(5), 1997, pp. 628-628
Authors:
ROMER W
HAUCK RW
SCHULZ C
DZEWAS B
LANGHAMMER HR
EMSLANDER HP
SCHWAIGER M
Citation: W. Romer et al., QUANTIFICATION OF THE EFFECT OF ENDOBRONCHIAL STENT IMPLANTATION BY VENTILATION AND PERFUSION SCINTIGRAPHY, The Journal of nuclear medicine, 37(5), 1996, pp. 137-137
Citation: Hr. Langhammer et R. Senekowitsch, VALUE OF NORMAL CA15-3 AND CEA LEVELS WIT H INCREASING TRENDS - COMMENT, Tumordiagnostik & Therapie, 16(1), 1995, pp. 39-39
Authors:
LANGHAMMER HR
ELLGAS W
LAUBENBACHER C
ERBAS B
BUSCH R
RIESINGER U
SENEKOWITSCH R
Citation: Hr. Langhammer et al., DETECTION IN RECURRENT BREAST-CANCER BY C A 15-3 AND CEA - INFLUENCE OF LOCALIZATION AND EXTENT OF METASTASES, Tumordiagnostik & Therapie, 15(3), 1994, pp. 96-103
Authors:
AVRIL N
JANICKE F
DOSE J
ZIEGLER S
HERTZ M
LANGHAMMER HR
GRAEFF H
SCHWAIGER M
Citation: N. Avril et al., FDG-PET IN THE ASSESSMENT OF SUSPICIOUS BREAST-TUMORS - COMPARISON WITH HISTOLOGY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000222-160000222
Authors:
LAUBENBACHER C
VANDEFLIERDT E
ALT A
WAGNERMANSLAU C
KRUSCHKE C
AVRIL N
LANGHAMMER HR
PABST HW
Citation: C. Laubenbacher et al., BIODISTRIBUTION OF IN-111 PENTETREOTIDE IN PATIENTS WITH CARCINOID-TUMORS, The Journal of nuclear medicine, 34(5), 1993, pp. 41-41